natgillin/translations-raw huggingface dataset:
Instanyl may affect or be affected by other medicines.
Instanyl može utjecati na druge lijekove, kao što i drugi lijekovi mogu utjecati na Instanyl.
Instanyl may interact with these medicines and you may experience mental status changes (e.g. agitation, hallucinations, coma), and other effects such as body temperature above 38°C, increase in heart rate, unstable blood pressure, and exaggeration of reflexes, muscular rigidity, lack of coordination and/or gastrointestinal symptoms (e.g nausea, vomiting, diarrhoea).
Može doći do interakcije Instanyla s tim lijekovima i mogli biste doživjeti promjene mentalnog statusa (npr. uznemirenost, halucinacije, komu) i druge posljedice kao što su povišenje tjelesne temperature iznad 38°C, ubrzani otkucaji srca, nestabilan krvni tlak, prenaglašeni refleksi, mišićna ukočenost, nekoordiniranost i/ili probavni simptomi (npr. mučnina, povraćanje, proljev).
Instanyl must be kept out of reach and sight of children.
Instanyl se mora čuvati izvan pogleda i dohvata djece.
Instanyl must not be used in patients who are not already taking opioids to maintain pain control, who have severe respiratory depression (inhibition of breathing) or who have severe obstructive lung conditions (diseases that severely impede breathing).
Instanyl se ne smije primjenjivati u bolesnika koji nisu prethodno uzimali opioide za kontrolu boli, bolesnika s teškom respiratornom depresijom (inhibicijom disanja) ili ozbiljnim opstruktivnim stanjem pluća (bolesti koje ozbiljno utječu na disanje).
Instanyl nasal spray is only indicated and licensed for the management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain.
Instanyl sprej za nos je indiciran i odobren samo za zbrinjavanje probojne boli u odraslih bolesnika koji već uzimaju opijatnu terapiju održavanja za kroničnu malignu bol.
Instanyl nasal spray is only indicated for the management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain.
Instanyl sprej za nos je indiciran samo za liječenje probojne boli kod odraslih bolesnika koji već uzimaju opijatnu terapiju održavanja za kroničnu malignu bol.
Instanyl nasal spray should be used only by physicians experienced, knowledgeable and skilled in the management of opioid therapy in cancer patients.
Instanyl sprej za nos smiju primjenjivati samo liječnici iskusni te posjeduju znanje i vještine u primjeni opijatne terapije kod bolesnika s karcinomom.
Instanyl nasal spray should not be used to treat any other short-term pain or pain status.
Instanyl sprej za nos se ne smije koristiti za liječenje druge kratkotrajne boli ili bolnih stanja.
Instanyl nasal spray should not be used to treat any other short-term pain or pain status.
Instanyl sprej za nos se ne smije koristiti za liječenje druge kratkotrajne boli ili bolnog stanja.
Instanyl should be used in the following way:
Instanyl treba koristiti na sljedeći način:
Instanyl should not be used in children and adolescents under 18 years of age.
Instanyl ne smiju koristiti djeca i adolescenti u dobi do 18 godina.
Instanyl should not be used in pregnancy unless clearly necessary.
Instanyl treba primjenjivati u trudnoći samo kad za time postoji jasna potreba.
Instanyl was more effective than placebo at treating breakthrough pain in cancer patients.
Instanyl je bio djelotvorniji od placeba u liječenju probojne boli u bolesnika oboljelih od raka.
Instead use formula feed for your child.
Umjesto toga, koristite zamjensku hranu za Vaše dijete.
Instead, a pandemic preparedness vaccine can be made to contain a bird flu virus strain that could potentially cause a future pandemic.
Umjesto toga, može se napraviti cjepivo za pripravnost na pandemiju koje sadrži soj virusa ptičje gripe koji bi mogao izazvati buduću pandemiju.
Instead, alternative and error-prone pathways are activated, such as the non-homologous end joining (NHEJ) pathway, leading to increased genomic instability.
Umjesto toga se aktiviraju drugi putovi kod kojih često dolazi do pogrešaka, poput povezivanja nehomolognih krajeva (non-homologous end joining, NHEJ), što povećava genomsku nestabilnost.
Instead, it must be placed onto the mucosa between the dog’s cheek and gum of the dog.
Mora se primijeniti na sluznicu između obraza i desni psa.
instillation site irritation
nadraženost na mjestu ukapavanja
Instillation site irritation, instillation site erythema, instillation site lacrimation.
Iritacija na mjestu ukapavanja, eritem na mjestu ukapavanja, suzenje na mjestu ukapavanja.
Instillation site pain.
Bol na mjestu ukapavanja.
Instillation site reaction, instillation site discomfort, instillation site pruritus, instillation site foreign body sensation.
Reakcija na mjestu ukapavanja, nelagoda na mjestu ukapavanja, svrbež na mjestu ukapavanja, osjećaj stranog tijela na mjestu ukapavanja.
Institution of positive–airway pressure during sleep as well as potential tracheostomy in clinically appropriate situations should also be considered.
Uvođenje pozitivnog tlaka zraka kroz dišne putove tijekom sna, kao i moguću traheotomiju u klinički prihvatljivim situacijama, mora se također uzeti u obzir.
Instituto Tecnológico PET, SA, 28040 Madrid, Spain
Instituto Tecnológico PET, SA, 28040 Madrid, Španjolska
INSTRUC TIO NS O N USE
UPUTE ZA UPORABU
Instruct the patient that any extra needles and swabs that remain after the final dose has been taken from the pen must be discarded appropriately and safely.
Objasnite bolesniku da sve suvišne igle i tupfere koji preostanu nakon davanja zadnje doze iz brizgalice mora zbrinuti na prikladan i siguran način.
Instruction for healthcare professionals to read the materials in conjunction with the SmPC.
Naputak zdravstvenim radnicima da te materijale čitaju zajedno sa Sažetkom opisa svojstava lijeka.
Instruction for opening and closing the box:
Upute za otvaranje i zatvaranje kutije
INSTRUCTION FOR PREPARATION OF RADIOPHARMACEUTICALS
UPUTE ZA PRIPREMU RADIOFARMACEUTIKA
Instruction for self-administration is mentioned in the Package Leaflet.
Upute za samoinjiciranje navedene su u Uputi o lijeku.
INSTRUCTION FOR THE HEALTHCARE PROFESSIONAL
UPUTE ZA ZDRAVSTVENE DJELATNIKE
Instruction for use
Upute za uporabu
Instruction in handling possible adverse reactions
Upute za zbrinjavanje mogućih nuspojava
Instruction on first aid after accidental exposure;
Upute o prvoj pomoći nakon slučajnog izlaganja;
Instruction on how to behave after accidental transmission.
Upute o tome kako se ponašati nakon slučajnog izlaganja.
Instruction on how to behave after administration and how and how often the dressing has to be changed and who should not change the dressing.
Upute o tome kako se ponašati nakon primjene te kako i koliko često se mora mijenjati zavoj te tko ne smije mijenjati zavoj;
Instruction on how to behave after administration/accidental transmission and how and how often the dressing has to be changed and who should not change the dressing;
Upute o tome kako se ponašati nakon primjene/slučajnog izlaganja te kako i koliko često se mora mijenjati zavoj te tko ne smije mijenjati zavoj;
Instruction on how to use NovoMix 30 suspension for injection in FlexPen.
Upute za uporabu NovoMix 30 suspenzije za injekciju u brizgalici FlexPen
Instruction on how to use NovoMix 50 suspension for injection in FlexPen.
Upute za uporabu NovoMix 50 suspenzije za injekciju u brizgalici FlexPen
Instruction on how to use NovoMix 70 suspension for injection in FlexPen.
Upute za uporabu NovoMix 70 suspenzije za injekciju u brizgalici FlexPen
Instruction on self-administration by subcutaneous injection is included in the Package Leaflet.
Upute za samoinjiciranje supkutanom injekcijom navedene su u Uputi o lijeku.
Instruction to seek emergency treatment by health care professionals in case of failure to gain venous access or in case of lack of efficacy
Upute za traženje hitnog liječenja od zdravstvenih radnika u slučaju neuspješnog pristupanja veni ili u slučaju izostanka djelotvornosti
Instruction to seek emergency treatment by healthcare professionals in the event of any adverse reactions during an infusion
bolesnika treba uputiti da potraži hitnu medicinsku pomoć u slučaju pojave nuspojava tijekom primjene infuzije
Instruction to seek emergency treatment by healthcare professionals in the event of any adverse reactions during an infusion
da bolesnik treba potražiti hitnu medicinsku pomoć u slučaju pojave nuspojava tijekom primjene infuzije
Instructional materials to share with patients.
Upute koje treba podijeliti bolesnicima
Instructions for administration
Upute za primjenu injekcije
Instructions for administration of Cosentyx solution
Upute za primjenu otopine Cosentyx
Instructions for administration of the vaccine
Upute za primjenu cjepiva
Instructions for administration of the vaccine presented in pre-filled syringe
Upute za primjenu cjepiva u napunjenoj štrcaljki
Instructions for administration of the vaccine presented in pre-filled syringe
Upute za upotrebu cjepiva u napunjenoj štrcaljki
Instructions for administration of the vaccine presented in pre-filled syringe
Upute za upotrebu cjepiva u napunjenoj štrcaljki:
Instructions for administration:
Upute za primjenu:
Instructions for alternate injection sites
Upute za zamjenska mjesta davanja injekcije
Instructions for children 3 years of age and above, weighing more than 40 kilograms
Upute za djecu od 3 godine i više, težine najmanje 40 kilograma
Instructions for determining the percent radioincorporation
Upute za određivanje postotka radioinkorporacije
Instructions for dilution
Upute za razrijeđivanje
Instructions for dose interruptions and reductions for pomalidomide related to haematologic adverse reactions are outlined in the table below:
Upute za prekid primjene i smanjenje doze pomalidomida zbog hematoloških nuspojava navedene su u tablici niže:
Instructions for handling
Upute za rukovanje lijekom
INSTRUCTIONS FOR HEALTH CARE PROFESSIONALS
UPUTE ZA ZDRAVSTVENE RADNIKE
Instructions for healthcare professionals
Upute za zdravstvene djelatnike
Instructions for injecting Abseamed under the skin
Upute za injiciranje Abseameda pod kožu
Instructions for injecting Binocrit under the skin
Upute za injiciranje Binocrita pod kožu
Instructions for injecting Epoetin alfa HEXAL under the skin
Upute za injiciranje Epoetina alfa HEXAL pod kožu
Instructions for injecting Herceptin using the administration system
Upute za injiciranje lijeka Herceptin pomoću sustava za primjenu
Instructions for injecting Herceptin using the administration system
Upute za injiciranje lijeka Herceptin uz pomoć sustava za primjenu
Instructions for injecting Plegridy
Upute za injiciranje Plegridyja
Instructions for injecting Plegridy BEFORE YOU START
Upute za injiciranje Plegridyja PRIJE NEGO POČNETE
Instructions for injecting with the Aranesp pre-filled pen
Upute za injiciranje Aranespa u napunjenoj brizgalici
Instructions for injecting with the Aranesp pre-filled pen (SureClick)
Upute za injiciranje Aranesp napunjene brizgalice (SureClick)
Instructions for injecting with the Aranesp pre-filled syringe
Upute za injiciranje Aranespa u napunjenoj štrcaljki
Instructions for injecting with the Prolia pre-filled syringe
Upute za injiciranje s Prolia napunjenom štrcaljkom
Instructions for injecting with the Ristempa pre-filled syringe
Upute za injiciranje Riste mpe napunje nom štrcaljkom
Instructions for injecting Zinbryta How to inject Zinbryta
Upute za injiciranje Zinbryte Kako injicirati Zinbrytu
Instructions for injection
Upute za primjenu injekcije
Instructions for keeping track of your injection sites and dates
Upute o praćenju mjesta injiciranja i datuma injiciranja
Instructions for opening and closing of the child-resistant box
Upute za otvaranje i zatvaranje kutije sigurne za djecu.
Instructions for opening and closing of the child-resistant box (for the multi-dose nasal spray) or the child resistant cap (for the multi-dose nasal spray DoseGuard) or opening of the blister (for the single-dose nasal spray)
Upute o otvaranju i zatvaranju kutije sigurne za djecu (za višedozni sprej za nos) ili zatvarača sigurnog za djecu (za višedozni sprej za nos DoseGuard) ili otvaranju blistera sigurnog za djecu (za jednodozni sprej za nos).
Instructions for opening and closing of the child-resistant box (for the multi-dose nasal spray) or the child resistant cap (for the multi-dose nasal spray DoseGuard) or opening of the blister (for the single-dose nasal spray).
Uputama o otvaranju i zatvaranju kutije sigurne za djecu (za višedozni sprej za nos) ili zatvarača sigurnog za djecu (za višedozni sprej za nos DoseGuard) ili otvaranju blistera (za jednodozni sprej za nos) sigurnog za djecu.
Instructions for opening and closing of the child-resistant box (for the multi-dose nasal spray) or the child resistant cap (for the multi-dose nasal spray DoseGuard) or opening of the blister (for the single-dose nasal spray).
Upute o otvaranju i zatvaranju vanjske kutije sigurne za djecu (za višedozni sprej za nos) ili zatvarača sigurnog za djecu (za višedozni sprej za nos DoseGuard) ili otvaranju blistera sigurnog za djecu (za jednodozni sprej za nos).
Instructions for preferred injection site
Upute za pogodno mjesto davanja injekcije
Instructions for preparation and handling and disposal
Upute za pripremu i rukovanje te zbrinjavanje
INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS
UPUTE ZA PRIPREMU RADIOFARMACEUTIKA
INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS
UPUTE ZA PRIPREMU RADIOFARMAKA
Instructions for preparing and giving a subcutaneous injection of ORENCIA:
Upute za pripremu i primjenu potkožne injekcije lijeka ORENCIA:
INSTRUCTIONS FOR PREPARING AND GIVING AN INJECTION OF CIMZIA
UPUTE ZA PRIPREMANJE I DAVANJE INJEKCIJE CIMZIJE
Instructions for preparing and giving an injection of Cimzia
Upute za pripremu i davanje injekcije Cimzije
INSTRUCTIONS FOR PREPARING AND GIVING AN INJECTION OF CIMZIA PRE-FILLED PEN
UPUTE ZA PRIPREMANJE I DAVANJE INJEKCIJE CIMZIJE
Instructions for preparing and giving an injection of Enbrel (See overleaf)
Upute za pripremu i primjenu injekcija Enbrel (vidjeti na poleđini)
Instructions for preparing and giving an injection of Enbrel (See overleaf).
Upute za pripremu i primjenu injekcija Enbrel (vidjeti na poleđini)
Instructions for preparing and giving an injection of Humira:
Upute za pripremu i davanje injekcije lijeka Humira:
Instructions for preparing and giving an injection of Nplate
Upute za pripremu i primjenu injekcije lijeka Nplate
Instructions for preparing and giving an injection of Nplate, at the end of this leaflet.)
Upute za pripremu i davanje injekcije lijeka Nplate, na kraju ove upute).
Instructions for preparing reduced doses of Zoledronic Acid Accord
Upute za pripremu sniženih doza Zoledronatne kiseline Accord
Instructions for preparing reduced doses of Zoledronic Acid Accord: Withdraw the appropriate volume of the liquid concentrate, as follows:
Upute za pripremu sniženih doza Zoledronatne kiseline Accord: Izvucite sljedeći odgovarajući volumen tekućeg koncentrata:
Instructions for preparing reduced doses of Zoledronic acid Actavis Withdraw an appropriate volume of the concentrate needed, as follows:
Upute za pripremu sniženih doza Zoledronatne kiseline Actavis Izvucite odgovarajući volumen potrebnog koncentrata, kako slijedi:
Instructions for preparing reduced doses of Zoledronic Acid Hospira: Withdraw the appropriate volume of the liquid concentrate, as follows:
Upute za pripremu sniženih doza Zoledronatne kiseline Hospira: Izvucite sljedeći odgovarajući volumen tekućeg koncentrata:
Instructions for preparing reduced doses of Zoledronic acid medac Withdraw an appropriate volume of the solution needed, as follows:
Upute za pripremu sniženih doza Zoledronatne kiseline medac Izvucite sljedeći odgovarajući volumen tekućeg koncentrata:
Instructions for preparing reduced doses of Zoledronic acid Mylan: Withdraw the appropriate volume of the liquid concentrate, as follows:
Upute za pripremu sniženih doza Zoledronatne kiseline Mylan: Izvucite sljedeći odgovarajući volumen tekućeg koncentrata:
Instructions for preparing reduced doses of Zoledronic Acid Teva: Withdraw the appropriate volume of the liquid concentrate, as follows:
Upute za pripremu sniženih doza Zoledronatne kiseline Teva Izvucite sljedeći odgovarajući volumen tekućeg koncentrata:
Instructions for proper use
Upute za pravilnu primjenu
Instructions for proper use in adults and adolescents (12 to less than 18 years of age)
Upute za pravilnu primjenu u odraslih i adolescenata (u dobi od 12 do manje od 18 godina)
INSTRUCTIONS FOR RECONSTITUTION AND ADMINISTRATION
UPUTE ZA REKONSTITUCIJU I PRIMJENU
Instructions for reconstitution of Cosentyx 150 mg powder for solution for injection:
Upute za rekonstituciju Cosentyx 150 mg praška za otopinu za injekciju:
Instructions for reconstitution of the vaccine with the solvent presented in ampoules:
Upute za pripremu cjepiva s otapalom raspoloživim u ampuli
Instructions for reconstitution of the vaccine with the solvent presented in pre-filled syringe:
Upute za pripremu cjepiva s otapalom raspoloživim u napunjenoj štrcaljki
Instructions for reconstitution:
Upute za rekonstituciju:
Instructions for taking INTELENCE for all patients
Upute za uzimanje INTELENCEa za sve bolesnike
Instructions for the preparation of the NexoBrid gel are given at the end of this leaflet in the section intended for medical or healthcare professionals.
Upute za pripremu gela NexoBrid nalaze se na kraju ove upute u dijelu namijenjenom samo zdravstvenim djelatnicima.
Instructions for use (see overleaf)
Upute za primjenu (vidjeti na poleđini)
Instructions for use and handling - storage conditions
Upute za uporabu i rukovanje – uvjeti čuvanja
Instructions for use and handling and special precautions for disposal
Posebne mjere za zbrinjavanje i druga rukovanja lijekom
Instructions for use and handling – reconstitution, dilution and administration
Upute za korištenje i rukovanje – rekonstitucija, razrjeđivanje i primjena
Instructions for use and handling – reconstitution, dilution and administration
Upute za uporabu i rukovanje – rekonstitucija, razrjeđivanje i primjena
Instructions for use and handling – reconstitution, dilution and administration
Upute za uporabu i rukovanje – rekonstitucija, razrjeđivanje i primjena otopine
Instructions for use and handling – storage conditions
Upute za uporabu i rukovanje – uvjeti čuvanja
Instructions for use and handling, and disposal
Posebne mjere za zbrinjavanje
Instructions for Use Contents
Upute za uporabu Sadržaj
Instructions for use for patients/ carers:
Upute za uporabu za bolesnike/njegovatelje:
INSTRUCTIONS FOR USE IN ADULT PATIENTS (Caspofungin Accord 50 mg) Step 1 Reconstitution of conventional vials
UPUTE ZA UPORABU U ODRASLIH BOLESNIKA (Caspofungin Accord 50 mg) Korak 1.
Instructions for use KwikPen
Upute za uporabu KwikPen
Instructions for use Morning
Upute za primjenu Ujutro
Instructions for use of Cosentyx powder for solution for injection The following information is intended for medical or healthcare professionals only.
Upute za uporabu Cosentyx praška za otopinu za injekciju Sljedeće informacije namijenjene su samo medicinskim ili zdravstvenim djelatnicima.
Instructions for use of Cosentyx pre-filled syringe
Upute za uporabu Cosentyx napunjene štrcaljke
Instructions for use of fentanyl buccal tablet and how to place the tablet
Uputa za opću primjenu bukalnih tableta fentanila te kako ih stavljati u usta
INSTRUCTIONS FOR USE OF ILARIS POWDER AND SOLVENT FOR SOLUTION FOR INJECTION (INJECTION KIT)
UPUTE ZA UPORABU ILARIS PRAŠKA I OTAPALA ZA OTOPINU ZA INJEKCIJU (KOMPLET ZA INJEKCIJU)
INSTRUCTIONS FOR USE OF ILARIS POWDER FOR SOLUTION FOR INJECTION
UPUTE ZA UPORABU ILARIS PRAŠKA ZA OTOPINU ZA INJEKCIJU
INSTRUCTIONS FOR USE OF INSTANYL NASAL SPRAY
UPUTE ZA PRIMJENU INSTANYL SPREJA ZA NOS
INSTRUCTIONS FOR USE OF INSTANYL SINGLE-DOSE NASAL SPRAY
UPUTE ZA PRIMJENU INSTANYL JEDNODOZNOG SPREJA ZA NOS
Instructions for use of the nasal spray device
Upute o upotrebi spreja za nos
Instructions for use of the nasal spray device
Upute za primjenu spreja za nos
Instructions for use of the nasal spray device
Upute za primjenu spreja za nos.
Instructions for use of the nasal spray device.
Uputama o primjeni spreja za nos.
INSTRUCTIONS FOR USE OF THE PODHALER DEVICE
UPUTE ZA UPORABU UREĐAJA PODHALER
Instructions for use of Ultibro Breezhaler inhaler
Upute za primjenu Ultibro Breezhaler inhalatora
Instructions for use of Ulunar Breezhaler inhaler
Upute za primjenu Ulunar Breezhaler inhalatora
Instructions for use of Xoterna Breezhaler inhaler
Upute za primjenu Xoterna Breezhaler inhalatora
INSTRUCTIONS FOR USE Read the following instructions carefully before using your Actrapid FlexPen.
UPUTE ZA UPORABU Prije uporabe brizgalice Actrapid FlexPen pozorno pročitajte ove upute.
INSTRUCTIONS FOR USE Read the following instructions carefully before using your Actrapid InnoLet.
UPUTE ZA UPORABU Prije uporabe brizgalice Actrapid InnoLet pozorno pročitajte ove upute.
INSTRUCTIONS FOR USE Read the following instructions carefully before using your Mixtard 30 FlexPen.
UPUTE ZA UPORABU Prije uporabe brizgalice Mixtard 30 FlexPen pozorno pročitajte ove upute.
INSTRUCTIONS FOR USE Read the following instructions carefully before using your Mixtard 30 InnoLet.
UPUTE ZA UPORABU Prije uporabe brizgalice Mixtard 30 InnoLet pozorno pročitajte ove upute.
Instructions for use Training
Upute za primjenu Poduka
Instructions for Use – please be guided by the pictograms to understand how to use this product.
Upute za uporabu - slijedite piktograme kako biste razumjeli kako koristiti ovaj proizvod.
INSTRUCTIONS FOR USE – PLEASE READ CAREFULLY
UPUTE ZA PRIMJENU – MOLIMO PAŽLJIVO PROČITAJTE
Instructions for use – preparation, handling and disposal
Upute za uporabu – priprema, rukovanje i odlaganje
Instructions for use – reconstitution, dilution and administration
Upute za uporabu - rekonstitucija, razrjeđivanje i primjena
Instructions for use – see the end of this Package Leaflet for how to prepare and give the medicine
Upute za primjenu – pogledajte upute o tome kako pripremiti i primijeniti ovaj lijek na kraju ove Upute o lijeku
Instructions for use, handling and disposal
Upute za uporabu, rukovanje i odlaganje.
Instructions for use/and handling, and disposal
Upute za uporabu/i rukovanje te odlaganje
Instructions for use/handling INOmax
Upute za upotrebu/rukovanje INOmax-om
Instructions for use:
Upute za uporabu
Instructions for use:
Upute za upotrebu:
Instructions for use: Refer to section 7 at the end of the package leaflet for instructions on how to use the Genuair inhaler.
Upute za uporabu: Upute za uporabu Genuair inhalatora potražite u dijelu 7 na kraju Upute o lijeku.
INSTRUCTIONS FOR USING THE VICTOZA PEN
UPUTE ZA UPORABU BRIZGALICE VICTOZA
Instructions how to handle possible adverse events including providing of batch number when reporting adverse drug reactions
Upute o tome kako zbrinjavati moguće nuspojave, uključujući davanje informacije o broju serije prilikom prijavljivanja nuspojava.
Instructions in handling possible adverse events
uputama za postupanje u slučaju mogućih nuspojava
Instructions in handling possible adverse events
upute za postupanje u slučaju mogućih nuspojava
INSTRUCTIONS IN USE
UPUTE ZA UPORABU
Instructions of how to reconstitute and dilute INVANZ: For single use only.
Upute za rekonstituciju i razrjeđivanje lijeka INVANZ: Samo za jednokratnu uporabu.
Instructions on correct injection procedures and disposal of used syringes
Upute o ispravnom postupku injiciranja i zbrinjavanju korištenih štrcaljki
Instructions on how to dilute, store and dispose of Topotecan Teva General precautions
Upute za razrjeđivanje, čuvanje i odlaganje lijeka Topotekan Teva Opće mjere opreza
Instructions on how to gently straighten your penis
Upute za nježno ispravljanje penisa
Instructions on how to gently stretch your penis
Upute za nježno istezanje penisa
Instructions on how to inject yourself (for patients receiving chemotherapy or adult patients scheduled for orthopaedic surgery only)
Upute za samostalnu primjenu injekcije (za bolesnike koji primaju kemoterapiju ili odrasle bolesnike u kojih se planira samo ortopedski kirurški zahvat)